Sionna Therapeutics (SION)
3.87
-0.28 (6.75%)
Upcoming Events
Latest Headlines
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference
October 8, 2026 4:30 PM - StreetInsider
Form 8-K Sionna Therapeutics, For: Sep 09
September 22, 2026 5:10 PM - SEC Filing
Form SCHEDULE 13D/A Sionna Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
September 21, 2026 6:57 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Sep 17 Filed by: RA Capital Nexus Fund, L.P.
September 21, 2026 6:57 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Sep 17 Filed by: Ridloff Elena
September 18, 2026 4:59 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Sep 17 Filed by: McKee Charlotte
September 18, 2026 4:58 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Sep 17 Filed by: Fitzpatrick Jennifer
September 18, 2026 4:57 PM - SEC Filing
Form 4 Sionna Therapeutics, For: Sep 17 Filed by: Cloonan Michael
September 18, 2026 4:52 PM - SEC Filing
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
September 17, 2026 5:10 PM - SEC Filing
Sionna Therapeutics (SION) Reiterated at Hold by Stifel - 'Remains a Show Me Story'
September 15, 2026 7:00 AM - StreetInsider
Sionna Therapeutics (SION) Reiterated at Market Perform by Citizens Amid Ph2a Trial Issues
September 15, 2026 4:42 AM - StreetInsider
Form 8-K Sionna Therapeutics, For: Sep 09
September 14, 2026 4:10 PM - SEC Filing
Sionna cuts 46% of staff, pivots to new CF drug combination
September 14, 2026 4:01 PM - StreetInsider
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
September 14, 2026 4:01 PM - StreetInsider
Freedom Broker Downgrades Sionna Therapeutics (SION) to Hold
August 11, 2026 10:09 AM - StreetInsider
Jones Trading Downgrades Sionna Therapeutics (SION) to Hold
August 10, 2026 3:53 PM - StreetInsider
LifeSci Capital Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 3:21 PM - StreetInsider
BTIG Downgrades Sionna Therapeutics (SION) to Neutral, 'we were wrong on our PreciSION CF call'
August 10, 2026 3:14 PM - StreetInsider
Guggenheim Downgrades Sionna Therapeutics (SION) to Neutral
August 10, 2026 1:15 PM - StreetInsider
RBC Capital Upgrades Sionna Therapeutics (SION) to Sector Perform
August 10, 2026 11:46 AM - StreetInsider
Citizens Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 11:45 AM - StreetInsider
Raymond James Downgrades Sionna Therapeutics (SION) to Market Perform
August 10, 2026 11:44 AM - StreetInsider
Wedbush Downgrades Sionna Therapeutics (SION) to Neutral
August 10, 2026 10:42 AM - StreetInsider
Vertex stock jumps as rival cystic fibrosis drug fails trial
August 10, 2026 10:01 AM - StreetInsider
Stifel Downgrades Sionna Therapeutics (SION) to Hold
August 10, 2026 9:22 AM - StreetInsider
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
August 10, 2026 8:04 AM - StreetInsider
Form 8-K Sionna Therapeutics, For: Aug 10
August 10, 2026 7:15 AM - SEC Filing
Sionna CF drug trial fails key endpoint; company halts program
August 10, 2026 7:00 AM - StreetInsider
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026 7:00 AM - StreetInsider
Sionna Therapeutics (SION) PT Raised to $59 at Raymond James
August 6, 2026 10:24 AM - StreetInsider
Sionna Therapeutics (SION) Misses Q2 EPS by 14c
August 6, 2026 8:51 AM - StreetInsider
Form 10-Q Sionna Therapeutics, For: Jun 30
August 6, 2026 7:20 AM - SEC Filing
Form 8-K Sionna Therapeutics, For: Aug 06
August 6, 2026 7:13 AM - SEC Filing
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
August 6, 2026 7:01 AM - Globe NewsWire
Full Article List
